In order to assess the stage of colorectal tumorigenesis at which chromosome 8p loss of heterozygosity (LOH) occurs, 56 sporadic adenomas were examined for LOH at four polymorphic loci which show frequent LOH in carcinomas. LOH was found in only 5 out of 51 (9.8%) informative adenomas, whereas studies with the same markers in 85 informative carcinomas showed a LOH of 45%. The adenomas showing LOH were all in the 'high-risk' clinicopathological category, being 10 mm or more in diameter and showing tubulovillous architecture. It is concluded that the chromosome 8p locus is involved preferentially in the development of carcinomas rather than adenomas.
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The development of colorectal cancer incorporates several discrete genetic events. Some are largely restricted to carcinomas, whereas others are found in both adenomas and carcinomas. Inactivaton of tumour-suppressor genes APC and DCC by mutation or loss occurs in the majority of both colorectal adenomas and carcinomas (Fearon & Vogelstein, 1990; Powell et al., 1992) . Similarly, activating mutations in K-ras oncogene occur with nearly identical frequency in carcinomas and larger adenomas (Fearon & Vogelstein, 1990 ). Presumably such lesions affect the expansion of neoplastic populations without directly conferring a malignant phenotype. In contrast, the p53 gene is inactivated in 75% of colorectal cancers but is not abnormal in adenomas except those displaying features of severe dysplasia, and this gene would appear to have a major role initiating malignant behaviour (Baker et al., 1990; Kikuchi-Yanoshita et al., 1992; Carder et al., 1993) . Such genetic lesions are of interest because they suggest the existence of genes involved in the critical transition from benign to malignant growth. We (Cunningham et al., 1993) and others have recently identified a region on chromosome 8p that exhibits frequent LOH in colorectal cancer, indicating a further putative oncosuppressor locus or loci. In this paper we assess the frequency of LOH at this region in sporadic colorectal adenomas to determine at what stage in evolution of colorectal tumours this molecular lesion exerts preferential selective advantage.
Loss of heterozygosity affecting chromosome 8p is found in over 50% of colorectal cancers (Cunningham et al., 1993) . A similar frequency of chromosome 8p LOH has been determined in bladder, prostate, lung and hepatocellular cancer (Bergenheim et al., 1991; Emi et al., 1992; Knowles et al., 1993) . In bladder and hepatocellular cancer, there is a correlation between chromosome 8p LOH and advanced tumour stage and grade Knowles et al., 1993) . In colorectal cancer we were unable to identify a correlation between chromosome 8p LOH and tumour site or Dukes stage (Cunningham et al., 1993) , although such an association with cdnicopathological stage has been suggested by others . In addition, the possibility of two separate chromosome 8p colorectal oncosuppressor loci has been proposed . This work addresses the question of the role of the chromosome 8p locus or loci in tumorigenesis by determining the frequency of loss of heterozygosity in 56 sporadic colorectal adenomas at four chromosome 8p loci which have shown a high frequency of LOH in colorectal cancers. The adenomas were gathered from both cancer-bearing and cancer-free bowel. The results suggest preferential involvement of the chromosome 8p locus in the later stages of colorectal tumorigenesis.
Materhk and methods DNA was purified from 56 sporadic colorectal adenomas and matched normal tissue, either blood or histologically normal colonic mucosa, obtained from 49 individuals. Thirty-three adenomas were colected from fresh colorectal specimens resected for malignant disease. Of the remainder, 16 were removed endoscopically from cancer-free bowel as part of a presymptomatic screening programme.
Analysis of LOH using (CA). repeat polymorphisns Three microsatellite (CA). repeat markers were employed which had shown a high frequency of LOH in colorectal cancers. ANK1 (Polymeropoulos et al., 1991) (Cunningham et al., 1993) . In this study we further analysed the same colorectal cancers at the D8S137 locus and found a frequency of LOH of 50% (27 out of 54 informative cases). The percentage LOH for each of these markers in colorectal cancers and adenomas is presented in Figure 1 . Of the 56 adenomas, 51
were informative with at least one marker, and of these only five (9.8%) showed loss of heterozygosity. In contrast, when used in the study of 120 colorectal cancers, these four markers detected a LOH in 38 out of 85 (Ichii et al., 1993) . Our series is likely to have included a higher proportion of tubulovillous lesions than this group of FAP adenomas, and this may account for the presence, albeit rare, of chromosome 8p LOH in the sporadic lesions reported here. Overall, our data suggest that the putative chromosome 8p tumour-suppressor gene is important in the later stages of tumorigenesis in the colon and rectum. This pattern is similar to that noted for the p53 gene (Baker et al., 1990; Kikuchi-Yanoshita et al., 1992) and strikingly different to that found in APC, DCC and K-ras (Fearon & Vogelstein, 1990; Powell et al., 1992) .
Thus, LOH at the 8p locus appears to be one of a select group of acquired genetic lesions preferentially associated with malignant change in colorectal epithelium. Others include abnormalities of p53 and aneuploidy. In several cell lineages, including colorectal mucosa, abnormalities of p53 are known to induce instability of the genome, of which aneuploidy is an example (Livingstone et al., 1992; Carder et al., 1993) . A further lesion, at the hMSH2 gene on chromosome 2p, is associated with hereditary non-polyposis colorectal cancer (HNPCC), a familial disorder characterised by the development of carcinoma without prior proliferation of benign lesions (Fishel et al., 1993; Leach et al., 1993) . This also appears to involve infidelity in DNA replication, characterised by variability in the length of microsatellite repeats between normal and tumour DNA (Aaltonen et al., 1993; Ionov et al., 1993; Thibodeau et al., 1993) . Such instability has been recorded in up to 28% (Thibodeau et al., 1993 ) of apparently sporadic colorectal cancers but is rare in adenomas (Young et al., 1993 
